Page last updated: 2024-11-07

fluprednisolone and Ache

fluprednisolone has been researched along with Ache in 2 studies

Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.

Research Excerpts

ExcerptRelevanceReference
"Difluprednate given 2 or 4 times a day cleared postoperative inflammation and reduced pain rapidly and effectively."9.14Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. ( Cooke, DL; Crockett, RS; Korenfeld, MS; Silverstein, SM; Vogel, R, 2009)
"Difluprednate given 2 or 4 times a day cleared postoperative inflammation and reduced pain rapidly and effectively."5.14Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. ( Cooke, DL; Crockett, RS; Korenfeld, MS; Silverstein, SM; Vogel, R, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ueki, Y1
Uetsu, N1
Ueda-Hayakawa, I1
Okamoto, H1
Korenfeld, MS1
Silverstein, SM1
Cooke, DL1
Vogel, R1
Crockett, RS1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification[NCT02973880]Phase 3180 participants (Actual)Interventional2017-10-15Completed
A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery[NCT00429923]Phase 3219 participants (Actual)InterventionalCompleted
A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery[NCT00430092]Phase 3219 participants (Actual)InterventionalCompleted
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

"Anterior Chamber Cell Grade of 0 on Day 8 (Difluprednate QID vs Placebo)."

"Measured on a 0 to 4 scale: 0 is ≤ 1 cell; 1 is 2-10 cells; 2 is 11-20 cells; 3 is 21-50 cells; 4 is > 50 cells." (NCT00429923)
Timeframe: Day 8 (QID)

,,
Interventionparticipants (Number)
Proportion of subjects w/AC cell grade=0 on Day 8
Difluprednate 0.05% BID0
Difluprednate 0.05% QID19
Placebo13

"Anterior Chamber Cell Grade of 0 on Day 8 (Difluprednate QID vs Placebo)."

"Measured on a 0 to 4 scale: 0 is ≤ 1 cell; 1 is 2-10 cells; 2 is 11-20 cells; 3 is 21-50 cells; 4 is > 50 cells." (NCT00430092)
Timeframe: Day 8 (QID)

,,
Interventionparticipants (Number)
Proportion of Subjects w/AC cell grade=0 on Day 8
Difluprednate 0.05% BID0
Difluprednate 0.05% QID18
Placebo7

Trials

1 trial available for fluprednisolone and Ache

ArticleYear
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count; Double-Blind Method; Emulsions; Female

2009

Other Studies

1 other study available for fluprednisolone and Ache

ArticleYear
Case of Japanese carpenter bee (Xylocopa appendiculata circumvolans) stings.
    The Journal of dermatology, 2017, Volume: 44, Issue:6

    Topics: Administration, Cutaneous; Aged; Animals; Bees; Female; Fluprednisolone; Glucocorticoids; Humans; In

2017